Literature DB >> 25180732

Fibrinolytics in parapneumonic effusions/empyemas.

George Thommi1, Christopher J Shehan2, Matthew T Mcleay3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25180732     DOI： 10.1378/chest.14-0706

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

1.  The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.

Authors:  Andrey A Komissarov; Galina Florova; Ali O Azghani; Ann Buchanan; William M Bradley; Chris Schaefer; Kathleen Koenig; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-10       Impact factor: 5.464

2.  Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.

Authors:  Xiong Khee Cheong; Andrea Yu-Lin Ban; Boon Hau Ng; Nik Nuratiqah Nik Abeed; Nik Azuan Nik Ismail; Nik Farhan Nik Fuad; Syed Zulkifli Syed Zakaria; Sheah Lin Ghan; Mohamed Faisal Abdul Hamid
Journal:  BMC Pulm Med       Date:  2022-05-17       Impact factor: 3.320

3.  Life-threatening pleural hemorrhage following intrapleural enzyme therapy and successful treatment with fibrin-thrombin sealant pleurodesis: a case report.

Authors:  Simon V Vun; David G Lance
Journal:  J Med Case Rep       Date:  2015-12-18

4.  Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema.

Authors:  Galina Florova; René A Girard; Ali O Azghani; Krishna Sarva; Ann Buchanan; Sophia Karandashova; Christian J DeVera; Danna Morris; Mignote Chamiso; Kathleen Koenig; Douglas B Cines; Steven Idell; Andrey A Komissarov
Journal:  Physiol Rep       Date:  2021-05

Review 5.  From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.

Authors:  Sophia Karandashova; Galina Florova; Steven Idell; Andrey A Komissarov
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.